Brain ischemia refers to a condition in which there is a reduction or cessation of blood flow to the brain, leading to a shortage of oxygen and nutrients necessary for brain tissue to function. This can result in the death or dysfunction of brain cells, potentially leading to brain damage or neurological deficits.
Download Sample PDF Copy https://www.theinsightpartners.com/sample/TIPRE00017682/
Treatment:
- Acute ischemic stroke: May require the use of clot-busting medications (like tPA, tissue plasminogen activator) if administered within a certain time window (usually within 3โ4.5 hours of symptom onset). Mechanical clot removal may also be an option in some cases.
- Antiplatelet or anticoagulant drugs: To prevent further clot formation.
- Surgical intervention: If thereโs significant narrowing of arteries, surgery like carotid endarterectomy or angioplasty might be needed.
- Rehabilitation: After the ischemic event, rehabilitation therapies (physical, occupational, and speech therapy) help the patient recover functionality and improve quality of life.
๐๐ก๐ ๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ: Taxus Cardium, Edwards Lifesciences Corporation, Boston Scientific Corporation, Merck KGaA, Medtronic, Cook Medical, Novartis AG, Boehringer Ingelheim International GmbH, Abbott, BD, Johnson and Johnson Services Inc.
About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.
Contact US
Contact Person: Ankit Mathur
E-mail:ย [email protected]
Phone: +1-646-491-9876